Safety of Tiotropium Prescription in Chronic Obstructive Pulmonary Disease (COPD): A survey in patients taking Tiotropium at the time of an admission to hospital with an Acute Exacerbation of COPD.

Not Applicable

Recruiting

• Conditions: Chronic Obstructive Pulmonary Disease; Respiratory - Chronic obstructive pulmonary disease

• Registration Number: ACTRN12615000492550
• Lead Sponsor: Medical Research Institute of New Zealand

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-05-19
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

i.Admitted to hospital with an AECOPD.

ii.Prescribed Tiotropium at the time of admission.

iii.Greater than or equal to 40 years of age on admission

Exclusion Criteria

i.Patients unwilling to complete the questionnaire(s).

ii.Patients in whom Tiotropium has been commenced during this admission.

iii.Patients who do not have the capacity to give full written informed consent to participate in the study (as judged by the investigator).

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Proportion of patients who used more than one actuation of Tiotropium per day on any of the seven days prior to this admission, as asked by a questionnaire developed specifically for the purposes of this study.[Assessed upon recruitment (at some stage during the participant's admission) but regarding Tiotropium use in the 7 days prior to admission.]